10x Genomics (TXG) Surpasses Q2 Earnings and Revenue Estimates

10x Genomics (TXG) came out with quarterly earnings of $0.28 per share, beating the Zacks Consensus Estimate of a loss of $0.35 per share. This compares to a loss of $0.32 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +180.00%. A quarter ago, it was expected that this life science technology company would post a loss of $0.45 per share when it actually produced a loss of $0.36, delivering a surprise of +20%.Over the last fou ...